Literature DB >> 21250919

Down-regulation of glial fibrillary acidic protein and vimentin by RNA interference improves acute urinary dysfunction associated with spinal cord injury in rats.

Terushige Toyooka1, Hiroshi Nawashiro, Nariyoshi Shinomiya, Katsuji Shima.   

Abstract

In spinal cord injury, glial scarring, a result of overexpressed intermediate filament (IF) proteins including glial fibrillary acidic protein (GFAP) and vimentin, is one of the largest obstacles in axonal regeneration. We postulated that specific suppression of IF proteins in the injured CNS might inhibit the excessive reactivity of astrocytes and thereby suppress glial scarring. siRNAs targeting GFAP and vimentin were transfected separately into C6 glioma cells and rat hippocampal astrocytes. These siRNAs suppressed both biphasic elements of each IF proteins: the ordinarily expressed elements having slow turnover and the immediately inducible elements stimulated by tumor necrosis factor-a (TNF-α). Moreover, adenovirus vectors expressing GFAP or vimentin siRNAs suppressed the proliferation of C6 glioma cells on days 3-9 after infection. Finally, each siRNA mixed with atelocollagen was applied together to the contused thoracic spines of spinal cord injury (SCI) model rats. The introduction of GFAP and vimentin siRNAs prevented the overexpression of IF proteins in the injured lesion (namely, in the white matter surrounding the long tract where the lateral funiculus exists and in the gray matter near the anterior horn neurons). Furthermore, the starting date of spontaneous voiding was significantly accelerated by application of GFAP and vimentin siRNAs. The inhibition of undesirable glial activity surrounding micturition-related pathways improved acute urinary dysfunction due to neurogenic bladder. In conclusion, the down-regulation of IF proteins by RNAi suppresses the overproliferation of reactive astrocytes and thereby might be an effective treatment for spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21250919     DOI: 10.1089/neu.2010.1520

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  11 in total

1.  Prospects of siRNA cocktails as tools for modifying multiple gene targets in the injured spinal cord.

Authors:  Felicia Mary Michael; Preeja Chandran; Khaviyaa Chandramohan; Krithika Iyer; Kevin Jayaraj; Revathidevi Sundaramoorthy; Sankar Venkatachalam
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-28

2.  Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations.

Authors:  Eduardo M Castaño; Chera L Maarouf; Terence Wu; Maria Celeste Leal; Charisse M Whiteside; Lih-Fen Lue; Tyler A Kokjohn; Marwan N Sabbagh; Thomas G Beach; Alex E Roher
Journal:  Neurochem Int       Date:  2012-12-08       Impact factor: 3.921

3.  A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin.

Authors:  Kiyoshi Teshigawara; Tomoharu Kuboyama; Michiko Shigyo; Aiko Nagata; Kenji Sugimoto; Yuji Matsuya; Chihiro Tohda
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 4.  Scar-modulating treatments for central nervous system injury.

Authors:  Dingding Shen; Xiaodong Wang; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

5.  Effect of adenovirus-mediated RNA interference of IL-1β expression on spinal cord injury in rats.

Authors:  W-P Lin; J-H Lin; B Cai; J-X Shi; W-J Li; G R Choudhury; S-Q Wu; J-Z Wu; H-P Wu; Q-F Ke
Journal:  Spinal Cord       Date:  2016-02-23       Impact factor: 2.772

6.  Photomechanical wave-driven delivery of siRNAs targeting intermediate filament proteins promotes functional recovery after spinal cord injury in rats.

Authors:  Takahiro Ando; Shunichi Sato; Terushige Toyooka; Hiroaki Kobayashi; Hiroshi Nawashiro; Hiroshi Ashida; Minoru Obara
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 7.  Gene delivery strategies to promote spinal cord repair.

Authors:  Christopher M Walthers; Stephanie K Seidlits
Journal:  Biomark Insights       Date:  2015-04-09

8.  Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury.

Authors:  Yona Goldshmit; Frisca Frisca; Alexander R Pinto; Alice Pébay; Jean-Kitty K Y Tang; Ashley L Siegel; Jan Kaslin; Peter D Currie
Journal:  Brain Behav       Date:  2014-01-13       Impact factor: 2.708

9.  RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity.

Authors:  Jayden A Smith; Alice Braga; Jeroen Verheyen; Silvia Basilico; Sara Bandiera; Clara Alfaro-Cervello; Luca Peruzzotti-Jametti; Dan Shu; Farzin Haque; Peixuan Guo; Stefano Pluchino
Journal:  Mol Ther Nucleic Acids       Date:  2017-11-24       Impact factor: 8.886

10.  Time dependent neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation.

Authors:  Fahim Ebrahimi; Marco Koch; Philipp Pieroh; Chalid Ghadban; Constance Hobusch; Ingo Bechmann; Faramarz Dehghani
Journal:  J Neuroinflammation       Date:  2012-05-08       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.